Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983

PURPOSE: To compare the efficacy of four cycles of paclitaxel–bleomycin, etoposide, and cisplatin (T-BEP) to four cycles of bleomycin, etoposide, and cisplatin (BEP) in previously untreated patients with intermediate-prognosis germ-cell cancer (GCC). PATIENTS AND METHODS: Patients were randomly assi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: de Wit, Ronald, Skoneczna, Iwona, Daugaard, Gedske, De Santis, Maria, Garin, August, Aass, Nina, Witjes, Alfred J., Albers, Peter, White, Jeffery D., Germa-Lluch, José R., Marreaud, Sandrine, Collette, Laurence
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2012
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295568/
https://ncbi.nlm.nih.gov/pubmed/22271474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.0171
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires